Mark Wisniewski is the Senior Director of Biopharmaceuticals at UCLA Technology Development Group.  He is responsible for the life science intellectual property developed at UCLA, including licensing, marketing staff, financial management and business development.  Prior to his current role, his career spanned multiple roles in biotech management, entrepreneurship and product commercialization in both start-up to Fortune 100 companies.  Mark was the Head of Special Projects at Prolacta Bioscience, a producer of human milk nutritional products for premature infants in the neonatal intensive care unit, leading strategic planning and business development. He was a Principal Advisor to the National Institutes of Health and National Cancer Institute’s Commercialization Accelerator Programs to early-stage biotech companies. Mark began his career at Baxter Healthcare in business development, strategic planning and R&D.  Mark received his MBA from the UCLA Anderson School of Management and his Masters of Immunology and Microbiology at the UCLA School of Medicine. 

,